Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019158 (
hepatitis
)
30,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Experimental infectious mouse
hepatitis
is associated with an increase in glutamic-oxaloacetic transaminase activity of the serum (
SGO
-T). A relationship appears to exist between the rise in
SGO
-T activity and (a) the size of the virus inoculum, (b) the blood virus titer, and (c) the degree of liver necrosis. Trauma to the liver following partial hepatectomy results in a rise in
SGO
-T activity in mice. Although mouse
hepatitis
differs from human
hepatitis
in the incubation period, histological changes, and natural course, both infections bring about comparable changes in
SGO
-T activity.
...
PMID:Glutamic-oxaloacetic transaminase activity of serum in mice with viral hepatitis. 1327 82
A major etiological risk factor for hepatocellular carcinoma (HCC) is infection by
Hepatitis
viruses, especially hepatitis B virus and hepatitis C virus. Hepatitis B virus and hepatitis C virus do not cause aggressive activation of an oncogenic pathway, but they transactivate a broad array of genes, cause chronic inflammation, and, through interference with mitotic processes, lead to mitotic error-induced chromosome instability (ME-CIN). However, how ME-CIN is involved in the development of HCC remains unclear. Delineating the effect of ME-CIN on HCC development should help in identifying measures to combat HCC. In this study, we used ME-CIN model mice haploinsufficient in Shugoshin 1 (
Sgo1
(-/+)) to assess the role of ME-CIN in HCC development. Treatment with the carcinogen azoxymethane caused
Sgo1
(-/+) ME-CIN model mice to develop HCCs within 6 months, whereas control mice developed no HCC (P < 0.003). The HCC development was associated with expression of early HCC markers (glutamine synthetase, glypican 3, heat shock protein 70, and the serum marker alpha fetoprotein), although without fibrosis. ME-CIN preceded the expression of HCC markers, suggesting that ME-CIN is an important early event in HCC development. In 12-month-old untreated
Sgo1
mice, persistent DNA damage, altered gene expression, and spontaneous HCCs were observed.
Sgo1
protein accumulated in response to DNA damage in vitro. Overall,
Sgo1
(-/+)-mediated ME-CIN strongly promoted/progressed development of HCC in the presence of an initiator carcinogen, and it had a mild initiator effect by itself. Use of the ME-CIN model mice should help in identifying drugs to counteract the effects of ME-CIN and should accelerate anti-HCC drug development.
...
PMID:Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice. 2574 Aug 22